750 related articles for article (PubMed ID: 29374430)
21. Tools to investigate the ubiquitin proteasome system.
Leestemaker Y; Ovaa H
Drug Discov Today Technol; 2017 Dec; 26():25-31. PubMed ID: 29249239
[TBL] [Abstract][Full Text] [Related]
22. Targeting the ubiquitin proteasome system: beyond proteasome inhibition.
Xolalpa W; Perez-Galan P; Rodríguez MS; Roué G
Curr Pharm Des; 2013; 19(22):4053-93. PubMed ID: 23181575
[TBL] [Abstract][Full Text] [Related]
23. Targeting the ubiquitin proteasome system in haematological malignancies.
Crawford LJ; Irvine AE
Blood Rev; 2013 Nov; 27(6):297-304. PubMed ID: 24183816
[TBL] [Abstract][Full Text] [Related]
24. Adaptive modification and flexibility of the proteasome system in response to proteasome inhibition.
Naujokat C; Fuchs D; Berges C
Biochim Biophys Acta; 2007 Sep; 1773(9):1389-97. PubMed ID: 17582523
[TBL] [Abstract][Full Text] [Related]
25. Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.
Collins I; Wang H; Caldwell JJ; Chopra R
Biochem J; 2017 Mar; 474(7):1127-1147. PubMed ID: 28298557
[TBL] [Abstract][Full Text] [Related]
26. The role of the ubiquitin-proteasome pathway in cancer development and treatment.
Ding F; Xiao H; Wang M; Xie X; Hu F
Front Biosci (Landmark Ed); 2014 Jun; 19(6):886-95. PubMed ID: 24896323
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitin-proteasome system (UPS) as a target for anticancer treatment.
Park J; Cho J; Song EJ
Arch Pharm Res; 2020 Nov; 43(11):1144-1161. PubMed ID: 33165832
[TBL] [Abstract][Full Text] [Related]
28. Autoregulation of the 26S proteasome by in situ ubiquitination.
Jacobson AD; MacFadden A; Wu Z; Peng J; Liu CW
Mol Biol Cell; 2014 Jun; 25(12):1824-35. PubMed ID: 24743594
[TBL] [Abstract][Full Text] [Related]
29. Proteasome substrate receptors and their therapeutic potential.
Osei-Amponsa V; Walters KJ
Trends Biochem Sci; 2022 Nov; 47(11):950-964. PubMed ID: 35817651
[TBL] [Abstract][Full Text] [Related]
30. Epidithiodiketopiperazines Inhibit Protein Degradation by Targeting Proteasome Deubiquitinase Rpn11.
Li J; Zhang Y; Da Silva Sil Dos Santos B; Wang F; Ma Y; Perez C; Yang Y; Peng J; Cohen SM; Chou TF; Hilton ST; Deshaies RJ
Cell Chem Biol; 2018 Nov; 25(11):1350-1358.e9. PubMed ID: 30146242
[TBL] [Abstract][Full Text] [Related]
31. Measurement of the Multiple Activities of 26S Proteasomes.
Kim HT; Collins GA; Goldberg AL
Methods Mol Biol; 2018; 1844():289-308. PubMed ID: 30242717
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitinated proteins promote the association of proteasomes with the deubiquitinating enzyme Usp14 and the ubiquitin ligase Ube3c.
Kuo CL; Goldberg AL
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):E3404-E3413. PubMed ID: 28396413
[TBL] [Abstract][Full Text] [Related]
33. The role of ubiquitin-proteasome-dependent proteolysis in the remodelling of skeletal muscle.
Taillandier D; Combaret L; Pouch MN; Samuels SE; Béchet D; Attaix D
Proc Nutr Soc; 2004 May; 63(2):357-61. PubMed ID: 15294055
[TBL] [Abstract][Full Text] [Related]
34. Chaperone-mediated 26S proteasome remodeling facilitates free K63 ubiquitin chain production and aggresome clearance.
Nanduri P; Hao R; Fitzpatrick T; Yao TP
J Biol Chem; 2015 Apr; 290(15):9455-64. PubMed ID: 25713068
[TBL] [Abstract][Full Text] [Related]
35. The ubiquitin-proteasome system.
Nandi D; Tahiliani P; Kumar A; Chandu D
J Biosci; 2006 Mar; 31(1):137-55. PubMed ID: 16595883
[TBL] [Abstract][Full Text] [Related]
36. [Ubiquitins, proteasomes, sumoylation and therapeutic application today and in future for cancer and other diseases. I. Ubiquitin-proteasome system and the transcription factor NF-kappaB].
Fuchs O; Neuwirtová R
Vnitr Lek; 2006 Apr; 52(4):371-8. PubMed ID: 16755993
[TBL] [Abstract][Full Text] [Related]
37. Targeting the ubiquitin pathway for cancer treatment.
Liu J; Shaik S; Dai X; Wu Q; Zhou X; Wang Z; Wei W
Biochim Biophys Acta; 2015 Jan; 1855(1):50-60. PubMed ID: 25481052
[TBL] [Abstract][Full Text] [Related]
38. Extended ubiquitin species are protein-based DUB inhibitors.
Krutauz D; Reis N; Nakasone MA; Siman P; Zhang D; Kirkpatrick DS; Gygi SP; Brik A; Fushman D; Glickman MH
Nat Chem Biol; 2014 Aug; 10(8):664-70. PubMed ID: 24997605
[TBL] [Abstract][Full Text] [Related]
39. mTOR inhibition activates overall protein degradation by the ubiquitin proteasome system as well as by autophagy.
Zhao J; Zhai B; Gygi SP; Goldberg AL
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15790-7. PubMed ID: 26669439
[TBL] [Abstract][Full Text] [Related]
40. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
von Mikecz A; Chen M; Rockel T; Scharf A
Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
